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Background: This descriptive study of the abdominal fat transcriptome takes advantage of two experimental lines
of meat-type chickens (Gallus domesticus), which were selected over seven generations for a large difference in
abdominal (visceral) fatness. At the age of selection (9 wk), the fat line (FL) and lean line (LL) chickens exhibit a
2.5-fold difference in abdominal fat weight, while their feed intake and body weight are similar. These unique avian
models were originally created to unravel genetic and endocrine regulation of adiposity and lipogenesis in meat-type
chickens. The Del-Mar 14K Chicken Integrated Systems microarray was used for a time-course analysis of gene
expression in abdominal fat of FL and LL chickens during juvenile development (1–11 weeks of age).
Results: Microarray analysis of abdominal fat in FL and LL chickens revealed 131 differentially expressed (DE)
genes (FDR≤0.05) as the main effect of genotype, 254 DE genes as an interaction of age and genotype and 3,195
DE genes (FDR≤0.01) as the main effect of age. The most notable discoveries in the abdominal fat transcriptome
were higher expression of many genes involved in blood coagulation in the LL and up-regulation of numerous
adipogenic and lipogenic genes in FL chickens. Many of these DE genes belong to pathways controlling the
synthesis, metabolism and transport of lipids or endocrine signaling pathways activated by adipokines, retinoid
and thyroid hormones.
Conclusions: The present study provides a dynamic view of differential gene transcription in abdominal fat of
chickens genetically selected for fatness (FL) or leanness (LL). Remarkably, the LL chickens over-express a large
number of hemostatic genes that could be involved in proteolytic processing of adipokines and endocrine factors,
which contribute to their higher lipolysis and export of stored lipids. Some of these changes are already present at
1 week of age before the divergence in fatness. In contrast, the FL chickens have enhanced expression of
numerous lipogenic genes mainly after onset of divergence, presumably directed by multiple transcription factors.
This transcriptional analysis shows that abdominal fat of the chicken serves a dual function as both an endocrine
organ and an active metabolic tissue, which could play a more significant role in lipogenesis than previously
thought.
Keywords: Adipogenesis, Transcriptional regulators, Hemostatic genes, Lipogenesis, Adipokines, Retinoic acid
signaling, Thyroid hormone action, Polygenic trait, Visceral obesity, Gene interaction networks, Canonical
metabolic/regulatory pathways* Correspondence: cogburn@udel.edu
†Equal contributors
1Department of Animal and Food Sciences, University of Delaware, Newark,
DE 19716, USA
Full list of author information is available at the end of the article
© 2013 Resnyk et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the orLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Resnyk et al. BMC Genomics 2013, 14:557 Page 2 of 26
http://www.biomedcentral.com/1471-2164/14/557Background
The chicken was the first avian species and domestic
animal selected for complete genome sequencing and as-
sembly [1]. Subsequently, the chicken has emerged as a
premier model in animal agriculture [2-4] and develop-
mental biology [5]. Although now recognized as a model
organism for biomedical research [6], the chicken has
not been extensively used for the study of human dis-
eases, especially metabolic disorders (i.e., insulin resist-
ance, diabetes, obesity and metabolic syndrome). Several
unique features of avian metabolism make the chicken
an interesting model for understanding the interactions
between genetic and endocrine factors that contribute to
development of obesity and related metabolic disorders.
In particular, chickens normally exhibit “hyperglycemia”
[7,8], insulin resistance [8-11], hepatic de novo synthesis
of lipids [12] and, like humans [13], abdominal (visceral)
fatness is a polygenic trait [14-19]. Despite their relative
insensitivity to insulin, acute immunoneutralization of
insulin in the chicken provokes differential expression of
more than a thousand genes in both liver and in skeletal
muscle [20]. In contrast, only 69 genes were differen-
tially expressed (DE) in abdominal fat of chickens fol-
lowing insulin immunoneutralization, albeit short-term
fasting produced a much larger change (1780 DE genes)
in transcription of abdominal fat genes [21]. This recent
work also shows a rather large decrease in expression of
lipogenic genes in abdominal fat of fasted chickens. A
detailed examination of the insulin signaling cascade in
adipose tissue of the chicken shows a distinct unrespon-
siveness to insulin [22]. Collectively, these observations
support the chicken as a unique model for the study of
the genetic and biological mechanisms controlling fat-
ness or leanness.
Most mammalian models of obesity exploit single gene
mutations or use high-energy, high-fat diets to induce
obesity [23]. Our chicken models are two experimental
lines of meat-type chickens that were divergently se-
lected over seven generations for either high (FL) or low
(LL) abdominal (visceral) fatness [24,25]. These chickens
exhibit a 2.5-fold difference in abdominal fat weight at 9
weeks (wk) of age, albeit their body weight and feed in-
take are similar [26]. Furthermore, the FL chickens
present hyperplasia and hypertrophy of adipocytes at an
earlier age than do LL chickens [27,28].
Differential abundance of lipogenic genes in liver of the
FL and LL chickens was determined earlier by differential
mRNA display [29], quantitative RT-PCR [30,31] or tar-
geted low-density array [32]. Our preliminary analysis of
the liver transcriptome in the FL and LL chickens during
juvenile development revealed 1,805 differentially ex-
pressed (DE) genes [3]. Quantitative trait loci (QTL) ana-
lyses of an FL x LL intercross identified a major QTL for
abdominal fatness at the distal end of chromosome 5(GGA5) [16,17,33]. Further, the expression quantitative
trait loci (eQTL) analysis of GGA5, involving a three gen-
eration intercross of the FL x LL chickens, identified varia-
tions in expression of 660 hepatic genes that were
correlated with abdominal fatness traits [19].
The present study has a dual purpose to explore the
abdominal fat transcriptome of juvenile FL and LL
chickens and to identify major gene networks controlling
adiposity and lipogenesis in these divergently selected
models. Using the Del-Mar 14K Chicken Integrated Sys-
tems cDNA microarray, we took transcriptional snap-
shots of gene expression in abdominal fat across two
genotypes (four birds/genotype) and six ages during ju-
venile development (1–11 weeks of age). Interestingly,
our time-course transcriptional analysis of abdominal fat
revealed numerous DE genes (main effect of genotype or
age × genotype interaction) that are involved in hemo-
stasis (14 genes), adipokine signaling (8 genes), retinol
metabolism (13 genes), and the synthesis (37 genes), oxi-
dation (12 genes) and transport (12 genes) of lipids. The
liver is widely considered as the major site of lipogenesis
in chickens and other birds. However, the present tran-
scriptional analysis of visceral adiposity has identified 37
lipogenic DE genes, including FASN, SCD, SREBF1,
SREBF2 and THRSPA that are expressed higher in FL
chickens. The greater abundance of thrombogenic en-
zymes and related protease inhibitors in abdominal fat
of the LL chickens suggests enhanced proteolytic pro-
cessing of adipokines and other endocrine factors, with
local and/or humoral actions, that could contribute to
their leaner phenotype. Although abdominal fat is gener-
ally considered as a passive depot for lipids, the present
descriptive study in FL and LL chickens supports our
idea that it does contribute to lipid synthesis and serves
as an endocrine organ, which liberates a host of
adipokines and endocrine factors with intrinsic and/or
extrinsic activity.
Methods
Animals and tissue collection
The birds were bred and raised at the Institut National
de la Recherche Agronomique (INRA) UE1295 Pôle
d’Expérimentation Avicole de Tours, F-37380 Nouzilly,
France. At hatching, FL and LL cockerels were wing-
banded and vaccinated against Marek’s disease virus.
Birds were reared together in floor pens (4.4 × 3.9 m)
and provided ad libitum access to water and conven-
tional starter feed for three weeks [3,050 kcal of
metabolizable energy (ME)/kg and 22% protein] and
thereafter with a grower ration (3,025 kcal ME/kg and
17.9% protein). Chicks were held under continuous light
(24 h or LL) for the first two days after hatching,
followed by a 14 h light/10 h dark cycle (14L:10D) for
the remainder of the experiment. Infrared gas heaters
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was decreased weekly from 32 C at hatching until 22 C
was reached at 3 wk of age. Eight birds from each geno-
type were randomly selected at six ages (1, 3, 5, 7, 9, and
11 wk), weighed, bled into heparinized syringes, and
killed by cervical dislocation. Abdominal fat was quickly
dissected and weighed; a sample was immediately snap
frozen in liquid nitrogen and stored at −75 C until fur-
ther processing. All animal procedures were performed
under the strict supervision of a French government vet-
erinarian and in accordance with protocols approved by
the French Agricultural Agency, the Scientific Research
Agency, and the Institutional Animal Care and Use
Committees at INRA, Nouzilly, France. These proce-
dures were also in compliance with the United States
Department of Agriculture (USDA) guidelines on the
use of agricultural animals in research and approved by
the University of Delaware Agricultural Animal Care
and Use Committee.
Microarray analysis
Four birds per genotype and age were randomly selected
from the total of eight birds sampled per genotype and age
for microarray analysis of abdominal fat (Additional file 1).
Total cellular RNA was extracted from abdominal fat
using guanidine thiocyanate and CsCl gradient purifica-
tion [34], followed by a separate step for DNase I treat-
ment. The RNA concentration was determined with a
NanoDrop ND-1000 spectrophotometer (NanoDrop
Technologies; Wilmington, DE). RNA integrity was ex-
amined using an RNA 6000 Nano Assay kit and the
Model 2100 Bioanalyzer (Agilent Technologies; Palo
Alto, CA) to assess the quality of the RNA samples
(RNA integrity number, RIN ≥ 9 was considered accept-
able). Twenty μg of total RNA was indirectly labeled
using SuperScript Plus Indirect cDNA Labeling System
(Invitrogen, Carlsbad, CA). First strand cDNA synthesis
was performed in a 30 μl final volume containing 1×
first-strand buffer, 5 μg of anchored oligo(dT20), DTT,
dNTP mix (including aminoallyl- and aminohexyl-
modified nucleotides), 40 U of RNaseOUT and 800 U of
SuperScript III reverse transcriptase with an incubation
at 46 C for 3 h. The original RNA template was removed
by NaOH hydrolysis, and followed by neutralization
with HCl. The cDNA was purified using a low-elution
volume spin cartridge (Invitrogen; Carlsbad, CA) and
labeled with either Alexa Fluor® 555 or Alexa Fluor®
647 succinimidyl ester in the dark at room temperature
for 2 h. After purification of labeled cDNA with a low-
elution-volume spin cartridge, the efficiency of dye in-
corporation was determined using the Microarray
Module on the NanoDrop ND-1000 spectrophotometer
and the Base:Dye Ratio Calculator on the Invitrogen
website [35].Twenty-four Del-Mar 14K Chicken Integrated Systems
microarrays (NCBI GEO Platform # GLP1731) were hy-
bridized with 48 labeled samples using a balanced block
design, where half of the birds from each genotype and age
were labeled with Alexa Fluor® 647 (red dye) and the other
half with Alexa Fluor® 555 (green dye; see Additional file 1
for details of the hybridization design). Hybridized slides
were scanned using a GenePix 4000B scanner with
GenePix Pro 4.1 software (Molecular Devices, Union
City, CA) at wavelengths of 635 nm (Alexa Fluor® 647-
labeling) and 532 nm (Alexa Fluor® 555-labeling) gener-
ating a combined TIFF image file for each slide. The
laser power was set at 100% with the photomultiplier
tube (PMT) setting being adjusted for each scan to pro-
duce a PMT count near unity. All slides were manually
checked for quality and all spots with inadequacies in
signal, background or morphology were eliminated from
further analysis. The image analysis results were merged
with Excel files in GenePix Report (GPR) format, which
contains clone identification, spot location on slide, and
most current gene name/function (based on BLASTX/
BLASTN score).
The microarray GPR files were analyzed using the lin-
ear models for statistical analysis of microarray data
(LIMMA, version 3.4.5) software [36] package in R (ver-
sion 2.11.1) [37]. Median intensities for each dye were
Loess normalized (without background subtraction)
within array and between array (“Aquantile” method) to
correct for dye and slide biases. A two-way analysis of
variation (ANOVA) was used on Loess normalized in-
tensity values from this factorial design experiment to
determine the main effect of genotype (G), main effect of
age (A), and the interaction of age and genotype (A × G).
The Benjamini-Hochberg procedure [38] was used to
control the experiment-wise false discovery rate (FDR)
from multiple testing procedures.
Quantitative RT-PCR analysis
Several DE and prior candidate genes were selected for
verification of expression by quantitative RT-PCR (qRT-
PCR) analysis. First-strand cDNA synthesis was performed
by incubation of a 13 μl reaction volume (containing 1 μg
of total DNase-treated RNA, 1 μl of 100 μM oligo dT20, 1
μl of 10 mM dNTP mix, and water to 13 μl total volume)
for 5 min at 70 C and then placed on ice for 2 min. A
master mix containing 5 μl of 5× first-strand synthesis
buffer, 1 μl of 0.1 M dithiothreitol (DTT), 1 μl of RN
aseOUT, and 200 U of SuperScript® III reverse transcript-
ase (Invitrogen, Carlsbad, CA) was added to the RNA in a
final reaction volume of 20 μl. The cDNA was diluted to
achieve a concentration of 50 ng/μl. Primers were
designed for qRT-PCR using Primer Express® v2.0 soft-
ware (Applied Biosystems, Foster City, CA). Detailed in-
formation for each primer pair including gene name, gene
Table 1 Phenotypic measurements from juvenile FL and
LL cockerels
Age (wk)
1 3 5 7 9 11
Body weight (kg)
FL 0.115 0.544 1.297 1.983 2.693 3.222
LL 0.123 0.551 1.204 1.964 2.787 3.281
Abdominal fat (g)
FL 0.5 13* 38* 88* 124* 150*
LL 0.4 5 * 15* 31* 54* 59*
FL/LL ratio 1.2 2.6 2.5 2.8 2.3 2.5
Abdominal fat (%BW)
FL 0.4 2.3* 2.9* 4.4* 4.6* 4.6*
LL 0.3 1.0* 1.2* 1.6* 1.9* 1.8*
FL/LL ratio 1.3 2.3 2.4 2.8 2.4 2.6
Values represent the least square means (LSMEANS) of eight birds/genotype and
age with a common standard error (not shown). Significance (denoted by *)
between FL and LL was determined at P≤0.05 using Fisher’s least significance
difference (LSD) test. Rows in boldface type present the FL/LL ratio of abdominal












Figure 1 Venn diagram showing unique and shared genes
among main effect of age (A) or genotype (G), and their
interaction (A × G). This diagram shows the number of
differentially expressed (DE) genes that are common across contrasts
and those that are unique to G (P≤0.05), A (P≤0.001), or the A × G
interaction (P≤0.05).
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Bank accession number and amplicon size are provided
in Additional file 2.
The qRT-PCR assay was performed in an ABI Prism
Sequence Detection System 7900HT, using Power SYBR®
green PCR master mix (Applied Biosystems, Foster City,
CA) and 400 nM of each primer (forward and reverse;
Sigma-Aldrich, St. Louis, MO) in duplicate wells. Disas-
sociation curves of each sample were analyzed to valid-
ate specific amplification and verify absence of primer
dimers. PCR products were analyzed using agarose gel
electrophoresis to compare approximate product size to
expected amplicon size. The Ct for each sample was nor-
malized to the corresponding sample geometric mean of
three housekeeping genes [protein kinase, AMP-activated,
beta 2 non-catalytic subunit (PRKAB2), protein kinase,
AMP-activated, gamma 1 non-catalytic subunit (PRKAG1),
and serpin peptidase inhibitor, clade E (nexin, plasminogen
activator inhibitor type 1), member 2 (PAI-2 or SERPINE2)].
These housekeeping genes were selected using the Ref
Finder website [39] as the most stably expressed genes
(i.e., genes with the lowest M-value) in the experiment.
The 2-(ΔΔCt) formula was used to calculate relative tran-
script abundance [40]. The statistical analysis was per-
formed using a general linear model procedure in SAS
v9.3. The data (log2 transformed normalized expression
values) was analyzed using a two-factor analysis of vari-
ance to determine significant effects of genotype (G),
age (A), and the interaction of age x genotype (A × G).
Pearson’s correlation coefficient (r) was used to com-
pare log2 FL/LL expression ratios between the micro-
array and qRT-PCR analyses of select genes.
Results
Phenotypic measurements
Body weight (BW, kg), abdominal fat weight (g), and
relative abdominal fat content (percent of body weight,
%BW) in juvenile FL and LL chickens are presented in
Table 1. The BW of FL and LL cockerels was similar for
all ages between 1 and 11 wk. The absolute and relative
abdominal fat weights of the FL chickens were 2.5-fold
higher (P≤0.01) than those of the LL at all ages between
3 and 11 wk of age.
Abdominal fat gene expression
Differentially expressed (DE) genes were defined as those
having a significant false discovery rate (FDR)-adjusted
P-value. The significance level was set at P≤0.05 for
genotype (G) and the age (A) × G interaction; or
P≤0.001 for A. The statistical analysis of this factorial de-
sign (2 genotypes × 6 ages) experiment provided DE
gene sets for the main effects of G and A, or the inter-
action of A × G. The main effect of G was determined
by comparing gene expression values of each genotype(FL vs. LL) averaged across the six juvenile ages (1–11 wk).
Likewise, the main effect of age (A) was determined by
comparing gene expression values of each age averaged
across both genotypes. To distinguish differences be-
tween ages, five single-degree-of-freedom contrasts
were made by comparing the average of each subse-
quent age (averaged across both genotypes) against the
1 wk average (1 vs. 3 wk, 1 vs. 5 wk, 1 vs. 7 wk, 1 vs. 9
wk and 1 vs. 11 wk). The Venn diagram (Figure 1) shows
the overall number of DE genes for G (344 genes), A
Table 2 Top biological functions of DE genes in
abdominal fat of juvenile FL and LL chickens*
Diseases and disorders P-value # Genes
Developmental disorder 2.76E-07 33
Hereditary disorder 3.01E-06 71




Metabolic disease 4.77E-05 41
Molecular and cellular functions
Lipid metabolism 6.06E-05 46










Embryonic development 1.06E-04 23
Cardiovascular system function 1.75E-04 8
Top canonical pathways P-Value Genes† Ratio†







Acute phase response signaling 5.11E-08 (15/178) 0.08
*Ingenuity® Pathway Analysis (IPA®) software was used for functional
annotation and mapping of the DE genes to canonical (metabolic/regulatory)
pathways, gene interaction networks, and interactive networks of
transcriptional factors that regulate differential expression of target genes. The
significance of representation (P-value) is determined by IPA based on the
number of DE genes (# Genes) found in each biological category divided by
the number of known genes assigned to that category by the Ingenuity®
Knowledge Base [42]. The bottom panel shows the significance of the
representation of DE genes in canonical pathways by IPA software. The
“Genes†” and “Ratio†” columns indicate the number of observed DE genes
divided by total number of genes assigned to each canonical pathway by the
Ingenuity® Knowledge Base.
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and the intersection of these DE gene sets. The number
of unique genes are indicated for G (119 DE genes), A
(3,183 DE genes) and the A × G interaction (32 DE
genes). There were 213 DE genes in common between
G and the A × G interaction. Thirty-one DE genes were
shared between A and G, whereas 28 DE genes were in
common between A and the A × G interaction. Overall, 19
DE genes were found in common among all three effects.
All DE genes involved in the higher order A × G inter-
action were removed from the main effects of A and G lists.
Therefore, the total number of DE genes presented in the
A × G interaction list (254 DE genes) in Additional file 3
reflects the 32 unique genes for the A × G interaction plus
those genes shared with the main effects of A (19 DE
genes) and G (194 DE genes). The number of DE genes
presented in the main effect of A (3,195 DE genes) and A
(131 DE genes) lists represent the total number of DE
genes for that effect minus those genes that belong to the
A × G interaction (Additional file 3).
Ingenuity® Pathway Analysis (IPA®) of DE gene sets
Significant genes (cDNA clone IDs) from the microarray
analysis were annotated using the GeneBase tool on our
website [41], which provides protein IDs (from GenBank
or Swiss-Prot databases) of microarray cDNA probes
derived from BLASTX analysis. Lists of DE genes
containing the protein ID and log2 ratio for each gene
were then submitted to the Ingenuity® Knowledge Base
[42] for functional annotation and mapping to canonical
metabolic and regulatory pathways. “Analysis ready”
genes were mapped by IPA for the genotype (100 DE
genes), age (2,301 DE genes), and age x genotype inter-
action (212 DE genes) lists. The IPA® Upstream Regula-
tor Analysis was used to identify transcription factor
(TF) interaction networks, predicted activation or inhib-
ition of TF, and their direct targets from DE gene sets.
A summary of the IPA “Diseases and Disorders” cat-
egory under “Biological Functions” is presented in Table 2.
The subcategories of major interest were “Developmental
Disorder” (33 genes), “Hereditary Disorder” (71 genes),
“Inflammatory Disease” (7 genes, out of which 6 were up
regulated in LL chickens), “Metabolic Disease” (41 genes),
and “Organismal Injury and Abnormalities” (31 genes). A
group of 33 genes were classified as “inborn error of me-
tabolism” in three of the above subcategories (Develop-
mental Disorder, Hereditary Disorder, and Metabolic
Disease) [see Additional file 4].
One gene interaction network identified by IPA was
heavily populated with a large number of hemostatic
genes, which were up regulated in abdominal fat of the LL
chickens (Figure 2). These genes are involved in coagula-
tion [F2, A2M, carboxypeptidase B2 (CPB2), fibrinogen
alpha (FGA), PLG, protein C (PROC) and serine peptidaseinhibitor, clade D, member 1 (SERPIND1)] and inflammation
[CD163 and retinoic acid receptor responder 2 (RARRES2)
or chemerin]. Another group of DE genes [taste receptor,
type 1, member 1 (TAS1R1), motilin receptor (MLNR), vaso-
active intestinal peptide receptor 1 (VIPR1), and omega-3
fatty acid receptor 1 (O3FAR1)] are G-coupled receptors
linked through the chemokine ligand CXCL12. Three genes
shown in this pathway are related to steroid metabolism
[hydroxysteroid (17-β) dehydrogenase 2 (HSD17B2) and
hydroxysteroid (17-β) dehydrogenase 7 (HSD17B7)] and
action [nuclear receptor subfamily 5, group A, member 1
(NR5A1)]. The transcription factor HNF1A regulates sev-
eral hemostatic genes (FGA, PLG, PROC and SERPINA1)





Figure 2 Gene interaction network in abdominal fat of LL chickens associated with hemostasis. Functional gene interactions networks
were identified by Ingenuity Pathway Analysis (IPA®) software. This network shows direct gene interactions mainly in abdominal fat of LL chickens
related to “Hematological System Development and Function” (A). The IPA® Upstream Regulator Analysis identified transcription factors with
direct actions on differentially expressed target genes in abdominal fat of FL and LL chickens. This analysis of upstream regulators (based on
expected responses from literature and observed responses in the data set) predicts inhibition (blue color) of hepatic nuclear factor 1A (HNF1A)
(B) and peroxisome proliferator-activated receptor gamma (PPARG) (C), which would lead to inhibition (blue edges or lines) of target gene
expression. Red gene symbols indicate higher expression in the FL and green gene symbols indicate higher expression in the LL.
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pressed at higher abundance of LL and several additional
genes up regulated in the FL (AGT, CTSL1, MCM7, SIM1,
TGFBR1 and TUBB), including three metabolic enzymes
(FASN, PDE3B and PYGL).
The higher expression of select hemostatic genes found
in abdominal fat of LL chickens was verified by qRT-PCR
analysis (Figure 3): serine proteases [F2, coagulation factor
IX (F9) and protein C (PROC)] and protease inhibitors
[A2M, annexin A5 (ANXA5), and SERPIND1]. Thrombin
(F2) was more abundant in abdominal fat of the LL at all
ages, except 11 wk. The expression of PROC was 3-fold
higher in the LL at 1 and 3 wk, and over 10-fold higher at






































































Figure 3 Verification of differential expression of hemostatic genes b
blood coagulation was determined by quantitative reverse transcription PC
(LSMEANS; n = 4 birds/genotype) of normalized expression values generate
System (SAS) software. A two-factor (genotye and age) analysis of variance
in each panel indicates significant effects of age (A), genotype (G) and/or t
error (SE) of LSMEANS for that gene as determined by the GLM procedureover expressed in visceral fat of the LL by 3-fold, 24-fold,
and 29-fold at 1, 5 and 7 wk, respectively. The expression
patterns of two serine proteases (F9 and PROC) were
similar with the greatest differences at 1 and 5 wk. The
qRT-PCR analysis shows similar expression patterns be-
tween some hemostatic factors and adipokines (Figure 4).
For example, the expression of ANXA5, F2, adiponectin
(ADIPOQ), adiponectin receptor 1 (ADIPOR1) and attrac-
tin (ATRN) were highest in abdominal fat of the LL at
9 wk. Similarly, expression profiles of A2M, retinol bind-
ing protein 4 (RBP4) and angiopoietin-like 4 (ANGPTL4)
were greatest in the LL at 7 wk. The adipokine visfatin [or
nicotinamide phosphoribosyltransferase (NAMPT)] was









































































y qRT-PCR analysis. The abundance of six genes associated with
R (qRT-PCR) analysis. Data points represent Least Squares Means
d by the general linear models (GLM) procedure in Statistical Analysis
(ANOVA) was used to determine significance (P≤0.05). The shaded box




























































































































































































Figure 4 Verification of differential expression of adipokines by qRT-PCR analysis. The abundance of eight adipokines was determined by
quantitative reverse transcription PCR (qRT-PCR) analysis. Data points represent LSMEANS (n = 4 birds/genotype) of normalized expression values.
A two-factor ANOVA was used to determine significance (P≤0.05). The shaded box in each panel indicates significant effects of age (A), genotype
(G) and/or the A × G interaction; the parenthesis shows the common standard error (SE) of LSMEANS for that gene determined by the GLM
procedure in SAS.
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the main effect of age (A) by microarray analysis, although
the log2 expression ratios were only slightly higher in the
FL. The qRT-PCR analysis shows that the expression of
ADIPOQ was higher (P≤0.05) in the LL between 7–11 wk
of age, while the abundance of ANGPTL4 was elevated at
1, 5, 7 and 11 wk of age, albeit only age (A) produced a
significant main effect.
The top canonical pathways identified by IPA
(Additional file 5) reflect the prevalence of hemostatic
genes in adipose tissue of LL chickens. The IPA software
provided functional assignments of DE genes to “Coagula-
tion System” (7 genes), “Acute Phase Response Signaling”
(15 genes) and “Intrinsic Prothrombin Activation” (6 genes)
pathways. These adipose genes include serine proteases
[F2, PLG, PROC, and complement factor B (CFB)], pro-
tease inhibitors [A2M, serine peptidase inhibitor clade
A member 1 (SERPINA1), and SERPIND1] and trans-
porters of retinol [retinol binding protein 4 (RBP4) and
7 (RBP7)]. The IPA functional category “Lipid Metabol-
ism” (Additional file 6) shows high representation of nu-
merous genes involved in “oxidation of lipid” (11/12 genes
higher in LL chickens), “transport of lipid” (9/12 genes
higher in LL chickens), “synthesis of lipid” (18/37 genes
up regulated in FL chickens) and “metabolism of retinoid”
(5/5 genes higher in LL chickens).
Higher expression of lipogenic genes in adipose tissue of
FL chickens
The abdominal fat of FL chickens exhibits higher expres-
sion of lipogenic transcription factors [sterol regulatory
element binding transcription factor 1 (SREBF1), thyroid
hormone responsive Spot 14 protein (THRSP) and sirtuin
2 (SIRT2)] (Figure 5A). In contrast, additional regulators
of transcription [THRSP-like (THRSPL) or MID1 inter-
acting protein 1 (MID1IP1); the nuclear liver X receptor-β
(LXRβ or NR1H2); and the proto-oncogene jun (JUN)]
were more abundant in abdominal fat of the LL. As shown
in this IPA gene interaction network, SREBF1 directly up
regulates several genes in the FL that are involved in lipid
biosynthesis [FASN, stearoyl-CoA desaturase (SCD), fatty
acid desaturase 2 (FADS2), sterol-C5-desaturase (SC5DL),
mevalonate decarboxylase (MVD), 7-dehydrocholesterol
reductase (DHCR7), 3-hydroxy-3-methylglutaryl-CoA re-
ductase (HMGCR) and lanosterol synthase (LSS)] and
ketogenesis [3-hydroxy-3-methylglutaryl-CoA synthase 2
(HMGCS2)]. Some of these genes are also targets of SIRT2
and THRSPA and differentially expressed in adipose tissue
of the FL. In addition, SREBF1 directly affects numerous
genes that are expressed higher in the LL [fatty acid de-
saturase 1 (FADS1), acetyl-CoA carboxylase alpha (ACACA),
acetoacetyl-CoA synthetase (AACS), farnesyl-diphosphate
farnesyltransferase 1 (FDFT1), solute carrier family 2
(SLC2A2; or facilitated glucose transporter 2, GLUT2),succinate-CoA ligase, alpha subunit (SUCLG1), and phos-
phomevalonate kinase (PMVK)]. Two JUN targets, prosta-
glandin D2 synthase (PTGDS) and MID1IP1 (which
regulates transcription of ACACA), were over-expressed
in adipose tissue of the LL. Insulin-like growth factor
binding protein 4 (IGFBP4) is another target of JUN that
was expressed at higher levels in FL adipose tissue. The
IPA Upstream Regulator Analysis predicts that JUN and
SREBF1 lead to activation (indicated by orange arrows) of
numerous up-regulated target genes (red symbols) in ab-
dominal fat of the FL chickens (Figure 5B and 5C). In con-
trast, the blue blunted lines show predicted inhibition and
down-regulation of DE genes by JUN (TP53) and SREBF1
(PCK1 and SLC2A2) in the LL (green symbols). The yel-
low arrows indicate that the IPA analysis would expect
these targets to be activated by JUN and SREBF1, rather
than down regulated as shown by these green gene sym-
bols. The majority of the up-regulated genes found in ab-
dominal fat of the FL (red symbols) are enzymes involved
in lipid metabolism.
The expression profiles of eight genes mainly associ-
ated with lipid metabolism were examined by qRT-PCR
analysis (Figure 6). A main effect (P≤0.05) of genotype (G)
was observed for FASN (4-fold increase in FL at wk 7),
SCD (4-fold and 3-fold increase in FL at wk 3 and 7, re-
spectively), and pyruvate dehydrogenase kinase, isozyme 4
(PDK4, over expressed in LL chickens from 7 to 11 wk). A
significant age by genotype (A x G) interaction (P≤0.05)
was observed for facilitated glucose transporter, member 1
(GLUT1), perilipin 2 (PLIN2) and lipoprotein lipase (LPL).
A main effect of age (A; P≤0.05) was also observed
for FASN, GLUT1, PLIN2, PDK4, LPL, facilitated glu-
cose transporter, member 8 (GLUT8) and superoxide
dismutase 3 (SOD3).
Another network populated by numerous DE genes
(up regulated in the FL) that control lipid metabolism
shows the interaction of four transcription regulators
(SIRT2, PPARD, EGR1 and CUX1), also up regulated in
visceral fat of the FL (Figure 7A). Peroxisome proliferator-
activated receptor delta (PPARD) interacts directly with
patatin-like phospholipase domain containing 2 (PNPLA2),
long chain acyl-CoA dehydrogenase (ACADL), amino-
acylase 1 (ACY1), aldehyde dehydrogenase 2 (ALDH2),
peroxiredoxin 6 (PRDX6), fatty acid binding protein 7
(FABP7), sorbitol dehydrogenase (SORD) and chemokine
(C-C motif) ligand 13 (CCL13). Early growth response 1
(EGR1) interacts with CCL13 and 3-hydroxy-3-methyl-
glutaryl CoA reductase (HMGCR), the rate-limiting en-
zyme in biosynthesis of cholesterol, which is a target of
the histone deacetylase sirtuin 2 (SIRT2). The ketogenic
enzyme 3-hydroxy-3-methylglutary-Coenzyme A synthase
2 (HMGCS2) is a downstream target of both SIRT2 and
PPARD. Three additional metabolic enzymes [lanosterol syn-
thase (LSS) and 7-dehydrocholesterol reductase (DHCR7)]
A 
Higher expression in FL
Higher expression in LL
B C 
Figure 5 (See legend on next page.)
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Figure 5 Transcriptional regulation of gene interaction network in abdominal fat of FL and LL chickens controlling lipogenesis.
Functional gene interactions and up-stream regulators were identified by IPA (gene symbols and color schemes as described in Figure 2). Direct
interactions (solid lines) were found among transcription regulators [JUN, SREBF1, SIRT2, MID1IP1, NR1H2 (LXRB) and THRSP] and lipogenic genes
(A). ✝THRSP and its paralog MID1IP1 (or THRSP-like, THRSPL) were not con sidered as transcription regulators by IPA software. THRSPA was added
to this network based on microarray and qRT-PCR analysis (Additional files 3 and 7) and known involvement of THRSP in regulating expression of
lipogenic enzymes across multiple species of birds and mammals. This analysis of upstream regulators predicts activation of JUN (B) and sterol
response element binding factor 1 (SREBF1) (C), which would lead to inhibition or activation [orange edges (lines)] expression of DE target genes.
Gene symbol color indicates higher expression in the FL (red) or higher expression (green) in the LL.
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acetoacetyl-CoA synthetase (AACS), fatty acid desaturase
1 (FADS1), and phosphomevalonate kinase (PMVK) were
more abundant in abdominal fat of the LL. The Ingenuity
Upstream Regulator Analysis identified several additional
targets of PPARD (Figure 7B), which were expressed at
higher levels in either the FL (FASN, FLT1, SCD and
TLR5) or the LL (ACAA, APOA4, BCL2, GPD2, SLC27A1,
SLC27A2, UCP3 and VLDLR) chickens. The IPA software
predicts that PPARD is inhibited (blue color) based on
prior knowledge of PPARD action in mammals and the
observed higher expression of PPARD-activated targets in
the LL (green symbols). IPA predicts that SIRT2 should be
activated (orange color) and has a direct positive action
on five target genes (DHCR7, HMGCR, LSS, MVD and
SC5DL), which were up regulated in adipose tissue of the
FL chickens. However, the yellow-colored arrows indicate
that IPA expected three target genes (AACS, FDFT1 and
PMVK) to be up regulated in the FL, rather than the LL as
we observed.
Ligand activated nuclear receptors and other
transcription factors
Of special interest are genes involved in ligand-activated
gene transcription (e.g., retinol and thyroid hormone signal-
ing) which regulate lipid metabolism (Table 3). Functional
annotation of DE genes by IPA analysis identified five genes
[alcohol dehydrogenase 1C (ADH1C), alcohol dehydrogen-
ase 5 (ADH5), cytochrome P450, family 2, subfamily E,
polypeptide 1 (CYP2E1), RARRES2 and RBP4] related to
“metabolism of retinoid” (Additional file 6). An additional
four retinol-related genes [RBP7, nucleolar protein 7
(NOL7), transthyretin (TTR) and retinol dehydrogenase
1 (RDH1)] were found by microarray analysis (Add-
itional file 3).
The qRT-PCR analysis of six candidate transcription fac-
tors is presented in Additional file 7. Four genes [peroxi-
some proliferator-activated receptor alpha (PPARA),
peroxisome proliferator-activated receptor gamma
(PPARG), PPARD and sterol regulatory element binding
transcription factor 2 (SREBF2) showed only a main effect
of age (A). A main effect of genotype (G) was observed for
SREBF1 due to higher expression in the FL at 1 and 5 wk.
Similarly, the abundance of retinoid X receptor, gamma(RXRG) was higher in adipose tissue of the FL at 1, 5 and
11 wk, which produced a main effect of genotype (G).
The abundance of eight additional genes controlling
metabolism and signaling of thyroid hormone and retinol
was examined by qRT-PCR analysis (Additional file 8).
Type I iodothyronine deiodinase (DIO1), which converts
the prohormone T4 to metabolically active T3, showed
only a main effect of age, whereas type III iodothyronine
deiodinase (DIO3) presented main effects of age and geno-
type due to a consistently higher abundance in abdominal
fat of LL chickens (Additional file 8-A). In contrast, the
transcriptional regulator THRSPA and thioredoxin inter-
acting protein (TXNIP) showed a main effect of age (A)
and genotype (G) with higher expression in visceral fat of
FL chickens at five of the six ages examined. Four genes
involved in retinol metabolism [beta-carotene 15, 15′-
monooxygenase (BCMO1), beta-carotene oxygenase 2
(BCO2), retinol saturase (RETSAT)] and the retinoic acid-
induced gene 3 (RAIG3) [or G protein-coupled receptor,
family C, group 5, member C (GPRC5C)] were also exam-
ined by qRT-PCR analysis (Additional file 8-B). Although
higher in the LL between 7 and 11 wk of age, BCMO1
produced only a main effect of age (A). The expression
of BCO2 sharply increased with age (main effect) and
was consistently higher in abdominal fat of the LL birds
(main effect of genotype). Similarly, RAIG3 showed
main effects of age and genotype, with higher expression
in the LL at 7 wk of age. The abundance of RETSAT was
higher in visceral fat of the FL at 3 and 9 wk. Further-
more, the retinoid ligand-activated transcription factor
RXRG was up-regulated in the FL, especially at 11 wk of
age (Additional file 7).
An array of DE and prior candidate genes was se-
lected for verification of gene expression using qRT-
PCR analysis (Table 3; Figures 3, 4 and 6; Additional
files 7 and 8). Pearson’s correlation coefficient (r) of
expression ratios (FL/LL) of 15 select genes
subjected to both microarray and qRT-PCR analyses
indicates a significant (P≤0.01) correlation between
the two methods (r = 0.64). The exclusion of two
genes with the lowest microarray FC estimate
(ANGPTL4 and ADIPOQ) greatly increased the Pear-






























































































































































































Figure 6 Expression of genes associated with lipid metabolism by qRT-PCR analysis. mRNA expressions of eight genes involved in lipid
metabolism were determined by quantitative reverse transcription PCR (qRT-PCR). Each data point represents LSMEANS (n = 4 birds/genotype) of
normalized expression values. A two-factor ANOVA was used to determine significance (P≤0.05). The shaded box in each panel indicates
significant effects of age (A), genotype (G) and/or the A × G interaction; the parenthesis shows the common standard error (SE) of LSMEANS for
that gene determined by the GLM procedure in SAS.






Figure 7 Transcriptional regulators of DE genes controlling lipogenesis in abdominal fat of FL and LL chickens. A large number of DE
lipogenic genes interact with two transcriptional regulators, SIRT2 and PPARD (A). The IPA Upstream Regulator Analysis (B) predicts that the up-regulation
of SIRT2 leads to activation of five lipogeneic genes (orange-edged arrows), whereas, the predicted inhibition of PPARD would lead to down
regulation (blue-edged arrows) of seven DE target genes in the FL [or up-regulation (green gene symbols) in the LL]. The predicted activation of major
lipogenic genes (ALDH2, CCL13, FASN and SCD) would be blocked (blunt orange arrow) by PPARD.
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by IPA shows interactions of several ligand-activated nu-
clear receptors and transcription regulators [RXRG, CEPBZ,
NR1H4 (farnesoid X receptor, FXR), THRA, THRSP,MID1IP1, nuclear receptor coactivator 1 (NCOA1), forkhead
box J1 (FOXJ1), and CCCTC-binding factor (CTCF)]. The
target genes of these upstream regulators were up regulated
in abdominal fat of the FL [GH, DNER, CYP2C9, ALAS1,
Table 3 Functional categories of DE and prior candidate genes expressed in abdominal fat and the average fold
change (FL/LL) as determined by microarray and/or qRT-PCR analyses
Functional category Symbol Gene name Microarray (FC)* qRT-PCR (FC)*
Hemostasis A2M Alpha-2-macroglobulin −1.89 −1.10
AGT Angiotensinogen 1.20 -
ANG Angiogenin −2.51 -
CFB Complement factor B −1.49 -
CPB2 Carboxypeptidase B2 −1.43 -
CPM Carboxypeptidase M −1.32 -
F2 Thrombin −1.85 −1.35
F9 Christmas factor −1.51 −4.04
FGA Fibrinogen alpha −2.61 -
PLG Plasminogen −1.79 -
PROC Protein C −1.39 −3.54
SERPINA1 Antitrypsin −1.75 -
SERPIND1 Heparin cofactor −2.00 −1.50
THBS2 Thrombospondin 2 −1.17 -
Adipokines ADIPOQ Adiponectin 1.03 −1.48
ANGPTL4 Angiopoietin-like 4 1.01 −1.58
ATRN Attractin −1.12 −1.22
CFD Adipsin 1.24 -
LPL Lipoprotein lipase - −1.41
NAMPT Visfatin - −1.20
RARRES2 Chemerin −1.32 −1.54
RBP4 Retinol binding protein 4 −2.33 −1.11
Lipogenesis DHCR7 7-Dehydrocholesterol reductase 1.11 -
FADS2 Fatty acid desaturase 2 1.21 -
FASN Fatty acid synthase 1.36 1.60
G6PC Glucose-6-phosphatase, catalytic subunit 1.46 -
scGH Growth hormone, chicken, short form 1.15 -
HMGCR 3-Hydroxy-3-methylglutaryl-CoA reductase 1.09 -
INSIG2 Insulin induced gene 2 1.74 -
LCAT Lecithin-cholesterol acyltransferase 1.32 -
MVD Mevalonate (diphospho) decarboxylase 1.20 -
SCD Stearoyl-CoA desaturase 1.48 1.88
SREBF1 Sterol regulatory element binding transcription factor 1 1.12 1.32
THRSPA Thyroid hormone responsive spot 14 A - 1.64
TXNIP Thioredoxin interacting protein - 1.80
Lipolysis ACAT1 Acetyl-CoA acetyltransferase 1 −3.18 -
ADH1C Alcohol dehydrogenase 1C (class I), gamma polypeptide −1.81 -
APOA1 Apolipoprotein A-I −1.16 -
APP Amyloid beta (A4) precursor protein −1.15 -
BCMO1 beta-carotene 15,15′-monooxygenase - −1.13
BCO2 beta-carotene oxygenase 2 −1.15 −1.48
CYP27A1 Cytochrome P450, family 27, subfamily A, polypeptide 1 −1.14 -
CYP2E1 Cytochrome P450, family 2, subfamily E, polypeptide 1 −1.80 -
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Table 3 Functional categories of DE and prior candidate genes expressed in abdominal fat and the average fold
change (FL/LL) as determined by microarray and/or qRT-PCR analyses (Continued)
EHHADH Enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase −1.09 -
GAMT Guanidinoacetate N-methyltransferase −1.21 -
HADHB Hydroxyacyl-CoA dehydrogenase (trifunctional protein) −1.10 -
HSD17B4 Hydroxysteroid (17-beta) dehydrogenase 4 −1.92 -
HSD17B6 Hydroxysteroid (17-beta) dehydrogenase 6 −1.19 -
IRS1 Insulin receptor substrate 1 −1.59 -
PDK4 pyruvate dehydrogenase kinase, isozyme 4 - −1.99
PHYH Phytanoyl-CoA 2-hydroxylase −1.56 -
SLC2A2 Facilitated glucose transporter 2 (GLUT2) −2.23 -
SOD3 superoxide dismutase 3, extracellular −1.10 −1.20
TP53 Tumor protein p53 −1.29 -
UCP3 Uncoupling protein 3 (mitochondrial, proton carrier) −1.21 -
*Fold-change (FC) represents the ratio of FL/LL transcript abundance averaged across six juvenile ages (1–11 wk). Prior candidate genes were identified as
differentially expressed (DE) genes by previous microarray or qRT-PCR analysis of previous genetic, nutritional or hormonal perturbation studies. Pearson’s
correlation coefficient (r) of expression ratios (FL/LL) of 15 select genes subjected to both microarray and qRT-PCR analyses indicates a significant (P≤0.01)
correlation between the two methods (r = 0.64). The exclusion of two genes with the lowest microarray FC estimate (ANGPTL4 and ADIPOQ) greatly increases the
Pearson correlation coefficient (r = 0.79) and the significance level (P≤0.001).
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SNX7] or LL chickens (CYP4F2, FABP1 and ACACA).
A final non-redundant set of genes involved in lipid
metabolism was identified by IPA from the G, A and A
× G DE gene lists and then was used for Ingenuity®Figure 8 Gene interaction network of nuclear receptors, co-activators
FL and LL chickens. This gene network shows direct interactions of seven
(FXR), NCOA1 or steroid receptor coactivator 1 (SRC-1), THRA, THRSP and MID
color indicates higher expression in the FL (red) or higher expression (greeUpstream Regulator Analysis. This analysis illustrates
the interaction of numerous ligand-activated nuclear re-
ceptors and other transcription factors (TF), providing
predictions of either an activated (orange color) or
inhibited (blue color) state (Figure 9). These predictionsUp-regulated in LL
Up-regulated in FL
and regulators of gene transcription in abdominal fat of juvenile
transcriptional regulators [CEBPZ, RXRG, NR1H4 or farnesoid X receptor
1IP1 (or THRSP-like, THRSPL)] and their target genes. Gene symbol





Higher expression in FL




Figure 9 Upstream regulators of gene transcription in abdominal fat of juvenile FL and LL chickens. Ingenuity® Upstream Regulator
Analysis revealed a large number of transcriptional regulators (see Table 4) controlling lipid metabolism genes in abdominal fat (A). This IPA
analysis shows “up-stream regulators” and their downstream targets found among DE fatty acid metabolism genes identified in abdominal fat of
the FL and LL chickens. Differentially expressed gene targets regulated by six additional transcription factors are shown (B). The IPA prediction of
activation (orange lines and symbols) or (blue lines and symbols) inhibition states is based on prior knowledge accrued by Ingenuity® Knowledge
Base and expression values of differentially expressed genes identified by microarray analysis of abdominal fat in juvenile FL and LL chickens.
Gene symbol color indicates higher expression in the FL (red) or higher expression (green) in the LL.
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sponses (from human and murine studies in the litera-
ture) and the responses of downstream targets found in
the DE gene data set. For example, this mechanistic net-
work of transcription regulators indicates whether the
TF (orange color) and target gene (red gene symbol) are
both activated or if the activity of the TF is inhibited(blue color), which would be associated with increased
expression in the LL (green gene symbol). This mechan-
istic network predicts inhibition (blue lines and symbols)
of eight transcription factors (PPARA, RXRA, NR1H2,
NR1H3, PPARD, PPARG, NROB2 and NR5A2) and the
activation (orange lines and symbols) of an additional
eight transcription factors (NR1H4, THRB, CEBPA,
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(Table 4). The gene targets are presented for two tran-
scription factors (PPARA and CEBPA) predicted to be
inhibited and four transcription factors (THRB, SREBF2,
CEBPB and CREB1) that were predicted to be activated
by the IPA Upstream Regulator Analysis. This mechanis-
tic analysis shows that three transcription factors
(PPARA, CEBPA and CEBPB) exert direct actions on
target genes up-regulated in the LL, while three other
transcription factors (THRB, SREBF2 and CREB1)
mainly target up-regulated genes in the FL, which are
involved in the synthesis, transport or metabolism of
lipids.Discussion
The divergent FL and LL chickens were originally de-
veloped as experimental models to study genetic and
endocrine mechanisms controlling excessive abdom-
inal fatness [43]. Indeed, juvenile FL and LL chickens
exhibit a 2.5-fold difference in abdominal fatness be-
tween 3 and 11 wk of age while maintaining similar
rates of growth (Table 1), feed intake, and energy me-
tabolism [44]. The divergence of adiposity between
the FL and LL chickens occurs at 3 wk of age [27];
hyperplasia of adipocytes was found as early as 2 wk
of age in the FL [28], followed by marked hyper-
trophy of adipocytes by 9 wk of age [27]. The FL
chickens appear to favor partitioning of energy and
nutrients into abdominal fat, whereas the LL deposit
more protein into skeletal muscle, especially breast
muscle [44]. A consistent feature of metabolism in
the FL chickens is a glucose-insulin imbalance, where
plasma glucose levels are lower and insulin levels are
slightly elevated [11,27]. The higher rate of lipogen-
esis observed in liver of FL chickens contributes to a
greater accumulation of abdominal fat in this geno-
type [45,46]. The search for major genes contributing
to the divergence in adiposity between the FL and LL
has primarily focused on the liver [3,19,29-32]. In the
present study, the Del-Mar 14K Integrated Systems
microarray was used to examine gene expression pro-
files of abdominal fat in juvenile FL and LL cockerels
across six ages (1–11 wk). This analysis of time-course
transcriptional profiles has provided the first panoramic
view of the abdominal fat transcriptome in the FL and
LL chickens and given functional insight into the 2.5-
fold divergence of adiposity. In particular, we have dis-
covered numerous DE genes that are involved in
hemostasis (blood coagulation), adipokine signaling,
thyroid hormone and retinol action, and lipogenesis in
abdominal fat of FL and LL chickens during juvenile de-
velopment. These findings are unlike previous micro-
array studies of adipose tissue in meat-type chickens.Higher expression of blood coagulation factors in adipose
tissue of LL chickens
A large number of genes involved in hemostasis were
differentially expressed in adipose tissue of LL chickens
(Table 3). Several coagulation factors identified in our
transcriptional analysis of adipose tissue are either pro-
teases (i.e., F2, F9, PLG, PROC, and CFB) or protease in-
hibitors (i.e., A2M, ANXA5, SERPINA1, and SERPIND1).
We also found higher expression of carboxypeptidases
[carboxypeptidase B2 (CPB2 or thrombin-activatable
fibrinolysis inhibitor) and carboxypeptidase M (CPM)]
in abdominal fat of LL chickens. Our discovery of a higher
abundance of several genes encoding blood clotting fac-
tors in LL chickens is quite peculiar given that fattening,
rather than leanness, in mammals is usually associated
with the prothrombotic state [47-50]. In fact, obesity in
humans is described as chronic low-grade inflammation
where expression of hemostatic genes [e.g., serine peptid-
ase inhibitor, clade E (nexin, plasminogen activator inhibi-
tor type 1), member 1 (PAI-1), thrombin, fibrinogen and
von Willebrand factor (VWF)] are positively associated
with greater deposition of adipose tissue [47,51]. The
adipokine PAI-1 (SERPINE1) encodes a secreted regulator
of fibrinolysis, which serves as a biomarker for metabolic
syndrome in humans [51]. Although PAI-1 has not been
mapped to the chicken genome, we did find higher ex-
pression of the plasminogen activator inhibitor 1 RNA-
binding protein (SERBP1) in abdominal fat of the FL
chickens. The SERBP1 protein greatly increases the deg-
radation of PAI-1 mRNA in rat hepatoma cells [52]. In
addition, SERBP1 functions as a partner with the proges-
terone receptor membrane component 1 (PGRMC1) in
mediating the anti-apoptotic action of progesterone on
the female reproductive tract of humans [53]. Our identifi-
cation of SERBP1 and its up-regulation in adipose tissue
of the FL suggest that a functional homolog of PAI-1 does
exist in the chicken. Another related member of the same
clade as PAI-I, SERPINE2 was not differentially expressed
in abdominal fat of FL and LL chickens according to
microarray analysis. Since SERPINE2 was one of the most
stably expressed genes in our qRT-PCR analysis, it was
used as a housekeeping gene to normalize gene expres-
sion. Another hemostatic gene up regulated in abdominal
fat of LL chickens was thrombospondin 2 (THBS2), which
inhibits adipogenesis in mammals [54].
Hemostatic proteins have several functions, some of
which include removal of signal peptides, activation
of zymogens, transport of enzymes, or degradation of
active enzymes. Given that many adipokines have a
high functional and structural similarity to the classic
coagulation factors and other hemostatic factors (e.g.,
ANGPTL4 contains a fibrinogen-like domain), it is reason-
able to assume that these proteases act on pre-pro
-adipokines or other secreted proteins expressed in
Table 4 Transcriptional regulators of genes that control the divergence of abdominal fatness in FL and LL chickens
Symbol NCBI Entrez gene name Activation z-score P-value of overlap # Target molecules
CEBPA CCAAT/enhancer binding protein (C/EBP), alpha 0.379 1.61E-15 34
CEBPB CCAAT/enhancer binding protein (C/EBP), beta 1.935 1.75E-10 25
CREB1 cAMP responsive element binding protein 1 0.527 1.64E-05 15
NR0B2 nuclear receptor subfamily 0, group B, member 2 (SHP) −0.84 3.74E-08 10
NR1H2 nuclear receptor subfamily 1, group H, member 2 (LXRB) −1.512 2.64E-10 12
NR1H3 nuclear receptor subfamily 1, group H, member 3 (LXRA) −0.2 4.69E-11 14
NR1H4 nuclear receptor subfamily 1, group H, member 4 (FXR) 1.076 1.40E-06 11
NR5A2 nuclear receptor subfamily 5, group A, member 2 (LRH1) −1.412 3.57E-04 7
PPARA peroxisome proliferator-activated receptor alpha −1.339 1.78E-32 54
PPARD peroxisome proliferator-activated receptor delta −0.767 3.13E-13 21
PPARG peroxisome proliferator-activated receptor gamma −1.629 1.38E-27 48
PPARGC1B peroxisome proliferator-activated receptor gamma, coactivator 1 beta 1.488 1.37E-12 12
RXRA retinoid X receptor, alpha −0.932 3.32E-18 31
SREBF1 sterol regulatory element binding transcription factor 1 0.511 2.91E-20 29
SREBF2 sterol regulatory element binding transcription factor 2 1.171 2.78E-15 17
THRA thyroid hormone receptor, alpha −0.246 2.08E-08 12
THRB thyroid hormone receptor, beta 1.135 7.18E-11 19
Ingenuity Upstream Regulator Analysis® identified multiple transcription factors (mainly ligand-activated nuclear factors) controlling a greatly amplified number of lipid
metabolism genes in abdominal fat during juvenile development (1–11 wk) of FL and LL chickens (see Figure 9). The activation Z-score indicates whether the observed gene
responses to upstream regulators agrees with expected changes derived from the literature and accrued in the Ingenuity® Knowledge Base [42]. A Fisher’s Exact Test was
used to determine the significance for enrichment of our target DE genes controlled by numerous upstream regulators and annotated in the Ingenuity® Knowledge Base.
Abbreviations: small heterodimer partner (SHP), liver X receptor alpha (LXRA), liver X receptor beta (LXRB), farnesoid X nuclear receptor (FXR), and liver receptor
homolog 1 (LRH1).
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blood coagulation genes in visceral fat or their role in the
development of adiposity in chickens. Using K-means
clustering (data not shown), we found that the expression
profiles for most genes involved in coagulation were clus-
tered with those of adipokines; this general trend was veri-
fied by qRT-PCR analysis (Figures 3 and 4). For example,
secreted proteins ADIPOQ and ATRN have expression
patterns that are similar to those of serine proteases (e.g.,
F2) and protease inhibitors (e.g., ANXA5). Further, the de-
velopmental profiles of RBP4 and ANGPTL4 were similar
to that of A2M, a protease inhibitor and transporter of cy-
tokines. The positive correlation of expression patterns be-
tween coagulation factors and adipokines is not surprising
given that many adipokines are associated with hemostatic
or inflammatory processes (e.g. RARRES2); and conversely,
several genes involved in coagulation are considered as
adipokines (e.g. PAI-1, A2M, F2 and FGA). Furthermore, a
similar transcriptional analysis of liver from the same indi-
vidual FL and LL birds failed to reveal differential expres-
sion of these blood coagulation factors [3]. The lack of a
parallel effect of genotype on hepatic expression of coagu-
lation factors in the FL and LL chickens suggests that their
ectopic expression in abdominal fat is specific and without
consequence to systemic hemostasis.Adipokines identified in abdominal fat of FL and LL
chickens
A prime example of proteolytic processing of adipokines
comes from our discovery of chemerin [or RARRES2
(retinoic acid receptor responder, tazarotene induced, 2)],
which is expressed at higher levels in abdominal fat of LL
chickens. Chemerin is a recently discovered adipokine that
regulates adipogenesis; and chemerin can be transformed
into a pro-inflammatory protein, a cell adhesion factor or
an anti-inflammatory peptide, depending upon cleavage
by specific proteases [55-57]. After removal of the N-
terminal signal peptide, pro-chemerin is processed at the
C-terminal end by serine proteases to generate an active
pro-inflammatory adipokine, which can be cleaved further
at its C-terminal end by cysteine proteases to generate an
anti-inflammatory peptide [58]. Active chemerin appears
to exert its action by binding its extracellular receptor
CMKLR1 on adipocytes and/or CCRL2 on activated mac-
rophages, which then forms an adhesive bridge between
these two resident cells in adipose tissue during the in-
flammatory response [58]. Adipocyte-derived chemerin
causes insulin resistance in skeletal muscle cells [59]; and
as a secreted adipokine, chemerin regulates myogenesis by
providing negative cross-talk between adipose tissue and
skeletal muscle [60]. Consequently, chemerin functions as
Resnyk et al. BMC Genomics 2013, 14:557 Page 19 of 26
http://www.biomedcentral.com/1471-2164/14/557a chemokine for leukocytes, an adipokine that regulates
angiogenesis, and a biomarker of metabolic syndrome and
obesity in humans [61-63]. However, chemerin appears to
be associated with leanness in the chicken.
Retinol binding protein 4 (RBP4), the main transporter
of retinol in blood, is another adipokine that was
expressed higher in abdominal fat of LL chickens at 5
and 7 wk of age. Like chemerin, RBP4 serves as a bio-
marker of obesity-related diseases including insulin re-
sistance, dyslipidemia, hypertension, and visceral obesity
in both adult and adolescent humans [64]. Similar to
other genes involved in coagulation, chemerin and RBP4
are expressed higher in LL, rather than FL chickens. In
contrast, several adipokines (ADIPOQ, ADIPOR1 and
ATRN) found in abdominal fat of FL and LL chickens
are regulated similar to mammals. For example, ADIPOQ
is inversely related to fatness and it is associated with in-
creased insulin sensitivity in mammals [65]. From the
qRT-PCR analysis, we observed late up-regulation of
ADIPOQ (wk 7–11) and its receptor ADIPOR1 (wk 9) in
LL chickens, which suggests that adipose tissue of FL
chickens could be less sensitive to insulin at these ages.
Attractin (ATRN) is a neuropeptide involved in melano-
cortin signaling and regulation of food intake, which sup-
presses diet-induced obesity [66]. Our qRT-PCR analysis
shows that the expression of ATRN markedly increases in
abdominal fat after 5 wk of age in both the FL and LL; fur-
thermore, the expression pattern of ATRN is strikingly
similar to that of ADIPOQ and ADIPOR1. The adipokine
ANGPTL4 was expressed higher in LL chickens at 1, 5, 7
and 11 wk of age, although this difference was not statisti-
cally significant by qRT-PCR analysis. Originally, ANGPT
L4 was identified as a secreted “fasting-induced adipose
factor (FIAF)” in the mouse that was sharply up regulated
by fasting and a target gene of the transcription factor
PPARA [67]. In fact, ANGPTL4 is a potent irreversible in-
hibitor of lipoprotein lipase (LPL) activity, which leads to
hypertriglyceridemia [68]. Our qRT-PCR analysis shows a
3-fold increase in expression of LPL in the LL chicken at 7
wk. Of particular interest, ANGPTL4 promotes the cleav-
age of LPL, while the proteolytic cleavage of ANGPTL4 by
proprotein convertase releases a more potent inhibitor of
LPL activity—the N terminal domain [69]. Thus, abdom-
inal fat of chickens is enriched with adipokines, which can
exert either local (autocrine/paracrine) or systemic (endo-
crine) actions after proteolytic processing and secretion
into circulation (Table 3).
Our initial survey of global gene expression in abdom-
inal fat of juvenile FL and LL chickens highlights another
important feature of the avian endocrine system—the vir-
tual absence of several important adipokines normally
found in mammals. A few examples of adipokines not yet
mapped to the current draft of the chicken genome
(galGAL4), include leptin (LEP), omentin (ITLN1), resistin(RETN), tumor necrosis factor alpha (TNFA), and PAI-1.
The existence of the chicken LEP gene remains a great
and unresolved controversy [70-74], especially since ex-
tensive expressed sequence tag (EST) [75] and whole
genome sequencing projects have failed to identify a
bona fide LEP gene in the chicken. Furthermore, the
LEP gene is absent from the genome of all birds se-
quenced so far (i.e., chicken, turkey, zebra finch, budg-
erigar and duck). However, the leptin receptor (LEPR)
gene is expressed in several chicken tissues [75-79]; and
chicken LEPR is capable of activating the JAK-STAT
pathway in vitro [80,81]. Similarly, components of TNF
signaling are up regulated in the hypothalamus of LL
chickens [79], although TNFA is yet to be identified in
chickens. Despite the absence of several mammalian
adipokines (i.e., LEP, TNFA, RETN, PAI-1, APOE, and
ITLN1) and metabolic enzymes (i.e., LIPE), adipogenesis
and lipid metabolism in the chicken are robustly regu-
lated by mechanisms that are, for the most part, similar
to those described in mammals.
Retinol metabolism and retinoic acid signaling in adipose
tissue
Another remarkable observation from the present study
was the over expression of 13 genes in abdominal fat of
LL chickens that control metabolism of retinol, the pre-
cursor of retinoic acid (RA), which itself is a major
chemical activator of multiple transcription factors con-
trolling lipogenesis. The primary source of retinol is
dietary plant-based β-carotene, which is symmetrically
cleaved by the enzyme β-carotene monooxygenase 1
(BCMO1) into two molecules of retinal. Recently, we
discovered mutations in the proximal promoter of
BCMO1, which are responsible for variation in the color
of breast meat in another F2 resource population of
meat-type chickens [82]. Another enzyme, β-carotene
oxygenase 2 (BCO2), asymmetrically cleaves one mol-
ecule of β-carotene to generate one molecule of retinal
and a by-product (e.g., β-apo-14′-carotenal), which acts
downstream to block signaling of PPARG [83]. The
BCO2 gene in chickens was originally identified as the
yellow skin gene, which controls the β-carotene content
and thereby yellow pigmentation of the skin [84]. Our
qRT-PCR analysis of these two β-carotene degrading en-
zymes (Figure 8), showed only a main effect of age on
expression of BCMO1, whereas the abundance of BCO2
was greater in abdominal fat of LL chickens, producing
a main effect of genotype. Another study found in-
creased expression of BCO2 in adipocytes from BCMO1
knockout mice and that dietary β-carotene reduces adi-
posity of mice—but only in the presence of a functional
BCMO1 enzyme [85]. This study also demonstrates the
importance of BCMO1 in generating the precursor (ret-
inal) for RA, which inhibits activation of PPARG and its
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zymes, adipokines and transport proteins (see Additional
file 6). Our study shows higher expression of both
BCMO1 and BCO2 in abdominal fat of the LL chickens
after 5 wk of age, which presumably would lead to gen-
eration of more retinal and RA. This idea is supported
by the differential expression of several genes involved
in retinol metabolism and RA signaling in adipose tissue
of FL and LL chickens. These genes are involved in
transport of retinol (RBP4, TTR and RBP7), metabolism
of retinol (RDH1, RETSAT, ADH1C, ADH5, and CYP2E1),
and respond to RA (RARRES2, GPRC5C, and NOL7). In
3T3-L1 preadipocytes, RA inhibits adipogenesis via up-
regulation of the transcriptional modulator SMAD3 [86].
Interestingly, two members of the SMAD family (SMAD5
and SMAD6) were up-regulated (main effect of age) in
adipose tissue of LL chickens (Additional file 3). The lig-
and (RA) activates its nuclear receptors (RAR and RXR),
which can form heterodimers with other ligand-dependent
transcription factors (e.g., LXR, PPARG and THR) to initi-
ate transcription of numerous downstream target genes.
Thus, RA seems to play an important role in reduction of
adipogenesis and adiposity in the LL chickens.
Visceral adipose tissue as a major site of lipogenesis in
chickens
Because the liver is widely considered as the primary site
of de novo lipid synthesis in birds, most transcriptional
studies of lipogenesis in the chicken have focused on
liver rather than adipose tissue. A targeted low-density
array enabled an initial transcriptional analysis of liver
[at a single age (8 wk)] in the FL and LL chickens [32].
This study showed up-regulation of several lipogenic
genes (ACACA, FASN, SCD, APOA1, SREBF1, and MDH2)
in the FL chickens. Examination of hepatic gene expression
at three ages (1, 4, and 7 wk) in another population of
chickens divergently selected on abdominal fatness re-
vealed differential expression of several genes involved in
lipid metabolism, including ACAT1,CEBPγ, FABP1, APOA1,
MDH1, APOD and PPARG [87]. A time-course (1–11 wk)
transcriptional study of liver in juvenile FL and LL chick-
ens revealed 1,805 differentially expressed (DE) genes,
mostly between 7 and 11 wk [3]. These functional genes
identified in the liver of juvenile FL and LL birds were
transcription factors, metabolic enzymes, transport pro-
teins, differentiation factors, signaling molecules and
adipokines.
In contrast, there have been only a few transcriptional
studies of adipose tissue in the chicken. For example, a
comparison of abdominal fat between meat-type (broiler)
and egg-type chickens (layer) at a single physical age
(10 wk), albeit at different physiological ages, focused
attention on the up-regulation of LPL in broiler chickens
and higher expression of APOA1 in layers [88]. Anotherstudy using abdominal fat samples taken at 7 wk from a
different population of divergently selected fat and lean
chickens reported the differentially expression of 230 adi-
pose genes [153 were up-regulated in the fat chickens,
while 77 were up-regulated in the lean birds] [89]. Their
conclusion that TNFA plays a key role in lipid metabolism
of the chicken is surprising, since this adipokine has not
been mapped to the chicken genome sequence. A recent
transcriptional study of chicken abdominal fat compared a
short-term (5 hr) fasting response with acute insulin
immunoneutralization [21]. Surprisingly, fasting provoked
larger changes in adipose gene transcription (1,780 DE
genes) than did insulin neutralization with only 92 DE
genes, which confirms the insensitivity of chicken abdom-
inal fat to insulin [22]. In contrast, more than a thousand
genes were either differentially expressed in liver or leg
muscle of the same birds following insulin immunoneu-
tralization [20]. Nonetheless, short-term fasting in the
chicken depressed the expression of 40 genes in abdom-
inal fat that are involved in the synthesis and storage of
lipid, while a number of adipose genes that control lipoly-
sis and oxidation of fatty acids were up-regulated by
fasting or insulin neutralization [21].
The present study has identified a large number of lipo-
genic genes that are up regulated in abdominal fat of FL
chickens (Table 3). A prime example of this lipogenic
group is our clone for GH1 (GenBank accession BI3904
57) that corresponds to the short form of chicken GH
(scGH), which lacks a signal peptide and is highly
expressed in ocular tissue [90,91], pituitary gland and
heart of chick embryos [91]. The short alternatively-
spliced (16.5 kDa) isoform of full length GH (20 kDa) ap-
pears to function as an “intracrine” factor within the cell
[91]. Our discovery of higher expression of scGH in ab-
dominal fat of the FL chicken supports the idea of a local
lipogenic action of GH on adipose tissue, rather than the
lipolytic response usually observed in mammals [92]. In
fact, our earlier work clearly established the lipogenic ac-
tion of exogenous GH in juvenile chickens [93-96].
Up-regulation of two transcription factors (SREBF1 and
THRSPA) and the histone deacetylase SIRT2 in abdominal
fat of the FL were accompanied by higher expression of
multiple genes involved in the generation and metabolism
of lipids (DHCR7, FADS2, FASN, HMGCR, HMGCS2,
LSS, MVD, SCD and SC5DL). The higher expression of
the transcription factor SREBF1 and 12 lipogenic target
genes in the FL strongly supports our idea that the diver-
gence in abdominal fatness of FL and LL chickens could
be related to differential expression of several lipogenic
genes in abdominal fat of the FL. For example, FADS2,
which catalyzes the rate limiting step in synthesis of highly
unsaturated fatty acids, was highly up regulated in abdom-
inal fat of FL chickens; binding sites for both SREBF1 and
PPARA are found in the promoter region of FADS2 [97].
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that control synthesis of fatty acids, including acetyl-CoA
carboxylase alpha (ACACA), which catalyzes the rate-
limiting step in fatty acid synthesis [98,99]. Furthermore,
MID1 interacting protein 1 (MID1IP1) [or THRSP-like
(THRSPL)] enhances ACACA polymerization and its en-
zymatic activity [100]. Adipose tissue from FL chickens
shows higher expression of THRSPA, a transcriptional
regulator of several lipogenic genes in the chicken
[3,78,96,101]. Earlier, we discovered a 9-base pair deletion
near the putative DNA-binding domain of chicken
THRSPA and demonstrated association of this insertion/
deletion polymorphism with abdominal fatness traits in
multiple resource populations of chickens [101]. Muta-
tions in the THRSPA gene of chickens [101-103], ducks
[104] and geese [105] are associated with fatness traits and
are perhaps of potential use as molecular markers in
poultry breeding programs. Furthermore, THRSP is a
major regulator of adipogenesis in skeletal muscle of beef
cattle [106,107] and of lipogenesis in the lactating mam-
mary gland of the dairy cow [108-110]. Interestingly, the
THRSP-null mouse shows reduced lipogenesis in the
mammary gland [111] and pups from the THRSP-null
mouse exhibit reduced body weight gain due to dimin-
ished milk triglycerides [112]. In humans, amplification of
the THRSP locus is associated with lipogenic breast can-
cer [113]; and, as such, THRSP serves as a marker of ag-
gressive breast cancer and a potential target of anti-cancer
drugs [114]. In humans, expression of THRSP in adipose
tissue is depressed by transition from a lipogenic fed state
to a lipolytic state induced by a 48 hr fast [115]. These ob-
servations support the idea that THRSP is a transcrip-
tional activator of several lipogenic enzymes (ACLY, FASN
and ME) in the mouse [116]. THRSP is activated in re-
sponse to T3, glucose and insulin and inhibited by polyun-
saturated fatty acids [117], cyclic AMP or glucagon [118].
Recent work has shown that induction of THRSP in-
creases expression of FASN in cultured hepatocyte cells
and RNAi-mediated knock-down of THRSP depresses ex-
pression of FASN [119]. Another study showed that FASN
co-precipitates with THRSP in nuclear extracts from the
mouse (referenced in [110]). The exact mechanism by
which THRSP and MID1IP1 interact and work as regula-
tors of gene transcription is currently unknown. These
genes are highly expressed in fatty tissues of birds and
mammals, where they regulate the expression and activity
of multiple lipogenic enzymes. The proximal (4 kb) pro-
moter region of THRSPA contains four putative binding
sites for PPARG and four SREBF sites (L.A. Cogburn, un-
published observations). In the present study, we found
higher expression of THRSPA in abdominal fat of FL
chickens at all ages, except at 7 wk. In the rat, the far-
upstream region of the THRSP promoter contains three
T3-THR response elements (TREs) [120]. Thus, THRSPAis responsive to metabolically active thyroid hormone (T3)
generated by the activation enzyme DIO1, whereas the en-
zyme DIO3 is responsible for degradation of metabolically
active T3 and conversion of the prohormone (T4) to meta-
bolically inactive reverse T3 (rT3) [121]. The up regulation
of DIO3 in adipose tissue of juvenile LL chickens (1–11
wk) suggests that less T3 would be available to activate
THRSPA transcription, which was observed in the LL.
Thioredoxin interacting protein (TXNIP) is another im-
portant regulator of hepatic glucose metabolism [122] that
also mediates hypothalamic control over energy utilization
and adiposity in the mouse [123]. The up-regulation of
TXNIP in abdominal fat of the FL during the period of
maximal fatness (3–11 wk) could contribute to their en-
hanced lipogenesis and adiposity. Likewise, we have dis-
covered another putative sensor of glucose, the sweet taste
receptor 1 (TAS1R1) gene, which is differentially expressed
in the hypothalamus [79] and abdominal fat (Figure 2) of
FL and LL chickens. Our observation of higher expression
of TAS1R1 in the hypothalamus of the FL and abdominal
fat of the LL suggest tissue specific regulation of this im-
portant tissue glucose sensor [124-126].
Increased lipolysis in abdominal fat of LL chickens
In contrast to the enhanced lipogenic state found in ab-
dominal fat of FL chickens, the LL show higher expres-
sion of numerous genes involved in lipolysis (Table 3).
Two cytochrome P450 family members (CYP27A1 and
CYP2E1) were expressed at higher levels in abdominal
fat of the LL when compared to FL chickens. CYP27A1
is involved in clearance of cholesterol via bile excretion,
whereas CYP2E1 is strongly induced in white adipose
tissue of the rat by prolonged fasting [127]. The beta-
subunit (HADHB) of mitochondrial tri-functional pro-
tein (MTP), a complex that catalyzes the final three steps
of β-oxidation of long chain fatty acids, was also up reg-
ulated in adipose tissue of LL chickens. MTP knockout
mice exhibit neonatal hypoglycemia and sudden neo-
natal death indicating its essential role in β-oxidation of
long chain fatty acids [128]. Two members of the
hydroxysteroid (17-β) dehydrogenase family (17β-HSD,
members 4 and 6) were also expressed higher in adipose
tissue of the LL. The significance of HSD17B4 in β-oxidation
of branched chain fatty acids was demonstrated in HSD
17B4 knockout mice, which were unable to degrade
phytanic and pristanic acids [129]. Since the other 17β-
HSD (HSD17B6) exhibits retinol dehydrogenase activity
[130], its up-regulation in adipose tissue of the LL chicken
suggests increased availability of all trans-retinoic acid. In
addition, PDK4, which inhibits the pyruvate dehydrogen-
ase complex and conversion of pyruvate to acetyl-CoA
[131], was highly up-regulated in abdominal fat of the LL
between 7 and 11 wk. The high expression of PDK4 in the
liver of chicken embryos [3], whose energy is derived
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PDK4 in adipose tissue of the LL chickens. Furthermore,
the expression of PDK4 increased sharply in abdominal fat
of two-week-old chickens by a 5-h fast or insulin immu-
noneutralization [21]. The tumor suppressor protein p53
enhances lipid catabolism and induces expression of
guanidinoacetate N-methyltransferase (GAMT), which
enhances β-oxidation of fatty acids [132]; both of these
genes were up regulated in visceral fat of the LL chickens.
Another gene up regulated in the LL that protects against
oxidative stress is SOD3, which is expressed at higher
levels in the liver of low-growth (leaner) chickens [3].
Thus, the present time-course transcriptional analysis of
abdominal fat in juvenile FL and LL chickens provides
compelling evidence for enhanced lipolysis in adipose tis-
sue of the LL.
Conclusions
The present study adds a new dimension to function of
visceral fat as a proteolytic processor of adipokines and
other endocrine signals that control lipid metabolism. In
particular, the LL cockerels exhibit high expression of
several blood coagulation factors in adipose tissue, albeit
not in liver. Some of these changes in the LL occur before
the divergence in fatness. These hemostatic proteases and
protease inhibitors could be involved in activation of
adipokines, chemokines and other metabolic ligands that
contribute to suppression of lipogenesis and adipogenesis
in the LL. Furthermore, abdominal fat of the LL chickens
has higher expression of genes involved in mobilization,
utilization and export of lipids than does the FL. Several
transcription factors have a larger number of target genes
expressed higher in the LL that could also favor suppres-
sion of abdominal fat accretion. In contrast, abdominal fat
of the FL chickens expresses a greater abundance of nu-
merous target genes involved in lipogenesis and adipoge-
nesis, which could contribute to their greater adiposity.
The higher expression of these target genes in FL chickens
appears after the onset of divergence in fatness. Therefore,
abdominal (visceral) fat of the chicken could play a more
significant role in lipogenesis and adiposity than previously
considered. The assumption that the liver of birds serves as
the major site of lipogenesis needs to be re-examined.
Availability of supporting data
The minimum information about microarray experiments
(MIAME)-compliant microarray data described in this art-
icle are available in the NCBI Gene Expression Omnibus
(GEO) under the accession number GSE37585. Additional
file 3 provides annotated DE gene sets from statistical ana-
lysis of the microarray data; whereas Additional files 4, 5,
6 provide annotation, functional analysis and mapping of
DE genes to biological functions and canonical pathways
by IPA software.Additional files
Additional file 1: Microarray experimental design. A Microsoft Excel
file containing a single work sheet “Array Hybridization Design” describes
the balanced block hybridization scheme used for the time-course
microarray analysis of abdominal fat in FL-LL chickens.
Additional file 2: Description of the primers used for the qRT-PCR
analysis. A Microsoft Excel file containing a single work sheet “Primer
information” provides the gene symbol, gene name, forward and reverse
primer sequences, GenBank accession and amplicon size (bp) for each
primer used for qRT-PCR analysis.
Additional file 3: Differentially expressed (DE) gene lists. A Microsoft
Excel file containing three work sheets (“Main Effect of Genotype”, “Age X
Genotype Interaction” and “Main Effect of Age”) that provide information
about DE genes identified as the main effect of genotype, age x
genotype interaction, or the main effect of age, respectively. Each list
provides the clone ID, gene symbol, gene name, Entrez protein ID, log2
ratio (FL/LL) and FDR adjusted P-value for each DE gene.
Additional file 4: IPA summary of DE genes related to diseases and
disorders. A Microsoft Excel file containing six work sheets. “Overall IPA
Summary” presents a synopsis of functionally annotated diseases and
disorders in abdominal fat of FL-LL chickens. This work sheet provides
information on IPA functional annotation, P-value for over-representation
of DE genes, a list of genes and the number of genes assigned to each
biological function. Five worksheets provide annotation of DE genes
listed in “Overall IPA Summary”. Each worksheet provides the Entrez
protein ID, gene symbol and log2 ratio for functionally annotated groups
of genes.
Additional file 5: IPA canonical pathways in abdominal fat of FL
and LL chickens. A Microsoft Excel file containing a single worksheet
“Canonical Pathways”. The top of the worksheet provides the canonical
pathway, P-value associated with over-representation and ratio (number
of genes present in dataset/number of known genes assigned to that
pathway in the Ingenuity® Knowledge Base. Below the summary, a table
for each canonical pathway provides the gene symbol and log2
expression ratio (FL/LL).
Additional file 6: IPA annotated DE genes in their molecular and
cellular function. This Microsoft Excel file contains two worksheets: “IPA
Summary” presents nine functional categories of DE genes found in
abdominal fat of the FL and LL chickens that are related to “Lipid
Metabolism”. This worksheet provides the biological function, P-values of
over-representation, the number of genes, and a gene list for each
functional category. Four of the functionally annotated groups (bold
type) are expanded in the second worksheet “Lipid Metabolism” to
include protein ID, gene symbol, and log2 expression ratio (FL/LL).
Additional file 7: Verification of differential expression of
transcription factors by qRT-PCR analysis. This PowerPoint slide file
shows qRT-PCR analysis of six transcription factors. Each data point
represents LSMEANS (n = 4 birds/genotype) of normalized expression
values. A two-factor ANOVA was used to determine significance (P≤0.05).
The shaded box in each panel indicates significant effects of age (A),
genotype (G) and/or the A x G interaction; the parenthesis shows the
common standard error (SE) of LSMEANS for that gene as determined by
the GLM procedure in SAS.
Additional file 8: qRT-PCR analysis of genes involved in thyroid
hormone and retinol metabolism and signaling. The abundance of
genes involved in signaling and metabolism of thyroid hormone (A., left side)
and retinol (B., right side) was verified by quantitative reverse transcription
PCR (qRT-PCR) analysis. Each data point represents LSMEANS (n = 4 birds/
genotype) of normalized expression values. A two-factor ANOVA was used
to determine significance (P≤0.05). The shaded box in each panel indicates
significant effects of age (A), genotype (G) and/or the A x G interaction; the
parenthesis shows the common standard error (SE) of LSMEANS for that
gene as determined by the GLM procedure in SAS.
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